United States · FDA National Drug Code directory
Dexamethasone Sodium Phosphate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-165_9dd90418-e564-4bc5-9077-506a1c2c1bce
- Product NDC
- 63323-165
- Form
- INJECTION, SOLUTION
- Composition / generic term
- DEXAMETHASONE SODIUM PHOSPHATE
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20000907
- Source listing expiry
- 20261231
Source-listed ingredients
- DEXAMETHASONE SODIUM PHOSPHATE — 4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 TRAY (63323-165-16) / 1 mL in 1 VIAL · 63323-165-16
- 25 VIAL, MULTI-DOSE in 1 TRAY (63323-165-26) / 5 mL in 1 VIAL, MULTI-DOSE · 63323-165-26
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →